Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Efficacy and Safety of Homeopathic Medicines in Diabetes, Pre-Diabetes, and Related Complications: Protocol for a Systematic Review and Meta-Analysis
A new protocol outlines a systematic review and meta‑analysis to assess the efficacy and safety of homeopathic medicines versus placebo in adults with pre‑diabetes, Type 1 or Type 2 diabetes, and related complications. The review will pool randomized and controlled clinical trials reporting glycaemic metrics such as fasting blood glucose, OGTT, HbA1c, as well as neuropathic symptom scores and adverse events. Searches span five major databases and multiple trial registries without language limits, employing Cochrane risk‑of‑bias tools and GRADE to evaluate certainty. Results will be disseminated through a peer‑reviewed journal to inform clinicians and policymakers.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2233852395-a516f81cbe77429a93e7841e74809c32.jpg)
Nearly 60% Skip Medical Treatment Due to High Costs—What You Can Do to Manage Your Health and Budget
A recent Alphaeon Credit survey of 500 respondents found that nearly 60% of Americans postpone or skip medical care because of cost. A 2021 federal rule now requires hospitals to publish price estimates online, yet compliance remains low, with only...
Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed
Matricis.ai announced a clinical collaboration with SimonMed to launch the first U.S. pilot of its EndomAI platform, which uses artificial intelligence to assist radiologists in detecting endometriosis on MRI scans. The study will evaluate AI‑enhanced reporting for diagnostic consistency, lesion...
FDA Grants Accelerated Approval to Tividenofusp Alfa for Neurologic Hunter Syndrome
The U.S. Food and Drug Administration granted accelerated approval to tividenofusp alfa, sold as Avlayah, as the first enzyme‑replacement therapy that crosses the blood‑brain barrier for neurologic Hunter syndrome. The drug combines iduronate‑2‑sulfatase with a transport protein to reach both...
AI to Predict How Bowel Cancer Patients Will Respond to New NHS Drug
Researchers at the Institute of Cancer Research in London and RCSI in Dublin unveiled PhenMap, an AI-driven platform that predicts which advanced bowel cancer patients will benefit from the NHS‑funded drug bevacizumab. The pilot study analyzed 117 European patients, integrating...
Connected Medical Devices: Smarter Care Starts Here
Connected medical devices (CMD) are becoming essential for gathering real‑world patient data and supporting decentralized clinical trials. Their integration—from wearable biosensors to continuous glucose monitors—requires dedicated service lines that manage calibration, storage, and data flow. Companies such as Marken are...
Student Athletes Feel the Heat as States Adapt to Climate Change
As extreme heat becomes routine, U.S. schools are scrambling to protect student athletes from life‑threatening heat illness. More than 9,000 high‑school athletes receive treatment each year, and nine deaths were recorded in 2021, prompting states to adopt their own heat‑safety...
Fix Operations, Not Contracts: How to Make Value-Based Care Work
Value‑based care (VBC) is stalling because providers focus on payment incentives rather than the operational changes needed to deliver coordinated, outcome‑driven care. A 2025 provider survey shows two‑thirds view analytics as essential, yet over half cite data quality and interoperability...
Predictive Analytics in Pharma Turns Lab Data Into Launch Strategies
Pharmaceutical firms pour over $300 billion into R&D each year, yet only about 12% of clinical‑trial candidates secure FDA approval. As therapies become more precise, identifying eligible patients and the physicians who treat them grows increasingly complex. Quest Diagnostics highlights that...
From Afterthought to Advantage: How Health Plans Are Rethinking Post-Acute Care
Health insurers are moving post‑acute care from a reactive afterthought to a proactive advantage. Real‑time clinical visibility and AI‑driven risk models now let care teams intervene while members are still in transition, rather than waiting for claims data. Integrated workflows...
Rethinking Dermatology Trial Design for Late-Stage Success
Advances in immunology have spurred many new dermatology therapies, but late‑stage trial failures often stem from outdated trial designs. Traditional short‑term efficacy endpoints like PASI or EASI miss critical data on durability, patient‑reported outcomes, and long‑term safety. Experts advocate incorporating...
From Vision to Reality: How Ambulatory Practices Actually Become Automated
Automation in ambulatory care is shifting from a buzzword to a daily reality, but success hinges on more than software. Practices that first map and standardize workflows—intake, eligibility, prior authorizations—create a solid foundation for automation tools. Engaging frontline staff early...
A Smarter Way for Employers to Offer GLP-1 Access — with Built-In Cost Control
GLP‑1 medications, once diabetes treatments, now dominate employee drug demand, pushing costs above $1,000 per member each month. Self‑funded employers face unpredictable utilization that threatens premium stability and talent retention. A growing solution is to carve GLP‑1 coverage out of...
The Seal Strength Paradox: Why More Is Not Always Better in Sterile Barrier Packaging
The article explains why increasing heat, pressure, or dwell time in sterile barrier packaging can backfire, leading to over‑sealing that weakens overall seal reliability. A real‑world case showed that boosting sealing temperature to fix intermittent tears actually introduced new failure...
Zebra Technologies and Aiva Health Team up on Nurse Solutions
Zebra Technologies and Aiva Health have joined forces to embed Aiva’s AI‑powered Nurse Assistant into Zebra’s HC20, HC50 mobile computers and WS101‑H wearable badge. The voice‑first solution enables nurses to document, submit work orders and retrieve policies hands‑free, reducing interruptions...
How Marta Bralic Kerns Built a $1.7 Billion Femtech Unicorn From a Mother’s Experience
Marta Bralic Kerns turned a frustrating pregnancy experience into Pomelo Care, a virtual maternal‑health platform now valued at $1.7 billion. Founded in 2021, the New York‑based company uses predictive analytics and 24‑hour clinical support to identify risks early and deliver personalized care...
Macao’s Health Tourism Gains Momentum with Wellness Expansion
Macao is accelerating its tourism‑plus‑big‑health strategy by opening several new medical facilities, including the Islands Healthcare Complex, iRad Hospital, a Wynn Palace medical center, and a Traditional Chinese Medicine museum. The government highlighted these assets at MITE 2026, promoting cross‑border...
Regeneron and Sanofi Report the EC Approval of Dupixent (Dupilumab) for Chronic Spontaneous Urticaria (CSU)
Regeneron and Sanofi announced that the European Commission has approved Dupixent (dupilumab) for moderate‑to‑severe chronic spontaneous urticaria in children aged 2‑11 who remain symptomatic despite antihistamines. The decision follows two Phase‑III studies—LIBERTY‑CUPID and CUPIDKids—that demonstrated significant reductions in UAS7 scores...
The More We Add To U.S. Healthcare, The Worse It Gets
U.S. healthcare is spiraling because providers respond to demand by adding staff, beds, and bureaucracy instead of redesigning care delivery. The article argues that subtraction—through economies of scale in outpatient groups and severity‑based segmentation in inpatient settings—can lower costs and...
‘I Will, Yeah’: How a Very Irish Phrase Presented a Challenge for an Immigrant Doctor
Migrant doctors in Ireland highlighted cultural misunderstandings that can jeopardise patient care, such as a common Irish phrase that led a GP to miss a smoking‑cessation intervention. At an Irish Medical Organisation conference, doctors from Sudan, Sri Lanka and Pakistan shared...
Health-Care Spending Surge Threatens Provincial Balance Sheets, Desjardins Warns
Desjardins Group’s latest report warns that soaring health‑care costs are outpacing economic growth and threatening the fiscal health of Canada’s provinces. Per‑capita spending has already eclipsed pandemic‑era peaks and continues to rise faster than GDP, while an aging population will...
Miracell Reports US FDA 510(k) Clearance for SMART M-CELL PRP and Bone Marrow Concentration Systems
Miracell announced that the U.S. Food and Drug Administration granted 510(k) clearance for its SMART M-CELL PRP Concentration System and Bone Marrow Concentration System, including the related kits. The clearance was based on substantial equivalence to the previously cleared SmartPReP...
Women of Influence: Healthcare 2026 – Kavitha Bhatia
Kavitha Bhatia, President and Chair of the Prime Healthcare Foundation and Chief Medical Officer of Strategy at Prime Healthcare, drives systemwide value creation and health‑equity initiatives. Under her leadership, Prime Healthcare has tripled in size, expanding its network through urgent‑care,...
Women of Influence: Healthcare 2026 – Jacqueline Bracy
Dr. Jacqueline Bracy, a veteran OB/GYN with roughly 30 years of service, was among the first female physicians elected chief of staff at Foothill Presbyterian Hospital. In 2013 she became president of Emanate Health Medical Group, overseeing a network that...
Women of Influence: Healthcare 2026 – Alexandra Busto
Alexandra Busto, a partner at Nixon Peabody, is a leading corporate and regulatory healthcare attorney. She advises providers on long‑term strategies, fee structures, and outpatient solutions that lower inpatient costs. Busto recently led the legal work for Tenor Health Foundation’s acquisition...
Women of Influence: Healthcare 2026 – Anita Chou
Anita Chou was appointed finance officer for Adventist Health’s Southern California network in January 2026, becoming the first woman to hold the role across its four hospitals. With more than 25 years of experience, she now oversees financial strategy, operational...
MoH Urges Hospitals to Accelerate Electronic Medical Records
Vietnam’s Ministry of Health (MoH) issued Document No.04/CT-BYT on April 7, ordering all hospitals to complete electronic medical record (EMR) implementation by Dec 31, 2026 and to cease paper records by 2027. The directive builds on existing laws and circulars and reflects...
A Pioneer Compilation on Ibrutinib-Loaded Hybrid Nanoformulations for Different Types of Cancer
Researchers Pandey, Gautam, and Singh review hybrid nanoformulations that encapsulate ibrutinib, a BTK inhibitor used for chronic lymphocytic leukemia and mantle‑cell lymphoma. The paper details how polymeric nanoparticles, liposomes, dendrimers and SNEDDS improve ibrutinib’s solubility, bioavailability, and pharmacokinetics while reducing...
Profile of Helen M. Piwnica-Worms
Helen M. Piwnica‑Worms, a veteran cancer biologist, has spent decades dissecting how tumor cells bypass cell‑cycle checkpoints and develop drug resistance. Her early work clarified the role of tyrosine phosphorylation in src and cdc2 regulation, laying groundwork for modern checkpoint...
The Push for Side-by-Side Prescription Pricing in EHR Workflows
The article argues that prescribing decisions now hinge on real‑time cost information, urging EHR platforms to display side‑by‑side insurance and cash pricing. A recent Buzz Health survey shows 75% of prescribers view out‑of‑pocket costs as a major barrier, while 94%...
Northwell Health Opens $6M New Interventional Radiology Suite
Northwell Health opened a $6 million, 1,100‑square‑foot interventional radiology suite at Long Island Jewish Medical Center, featuring a Philips Azurion 7 eight‑axis 3‑D imaging system. The facility adds to an existing IR program, enabling advanced cancer biopsies and neuro‑interventions while delivering lower...
Lawmaker Questions Delayed Maran Hospital
A lawmaker has flagged the prolonged stall of the RM150 million (≈$33 million) Maran Hospital project, which was first approved under the 11th Malaysia Plan and re‑approved with an additional RM350 million (≈$77 million) in the 2023 budget. Groundbreaking took place in 2018, but...
Massively Better Healthcare, a Review
Matthew Holt reviews Halle Tecco’s *Massively Better Healthcare*, a three‑part guide aimed at newcomers to U.S. health‑care entrepreneurship. The first section sketches the tangled American system, the second delivers practical innovation and company‑building advice, and the final part outlines four rules...
Why AI Vendors Struggle to Compete With EHRs
A new JAMA article highlights how entrenched electronic health record (EHR) vendors dominate AI adoption in U.S. hospitals, making it difficult for independent AI firms to gain traction. HealthAffairs data show 79% of hospitals use AI from their EHR vendor...
Access Consortium Sign up to Digitisation
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has taken the chair of the Access Consortium and unveiled a 2026 action plan focused on shared digital infrastructure and work‑sharing. The five member regulators—Australia, Canada, Singapore, Switzerland and the UK—aim...
Re: AI Supported Diagnostic Innovations for Impact in Global Women’s Health
In a response to Linder et al.’s analysis of AI‑driven women’s health diagnostics in low‑ and middle‑income countries, Mon Yee Htet Paing highlights China’s rapidly expanding AI medical‑device ecosystem as a practical template. Between 2020 and 2025, China approved 154 AI‑based devices, with approvals...
Private Firms Providing Services to NHS Made £1.6bn Profit in Two Years, Research Finds
Research by the Centre for Health and the Public Interest shows private firms earned roughly $2.0 bn in profit from NHS contracts over 2023‑24 and 2024‑25, based on about $15.2 bn of work. The analysis of 760 providers uncovered that $2.5 bn of...
PFAS 'Forever Chemicals' Found in Homes May Be Quietly Weakening Your Child's Bones, New Study Warns
A longitudinal study of 218 North American children found that higher blood levels of per‑ and polyfluoroalkyl substances (PFAS), especially PFOA, are associated with reduced bone mineral density in the lower arm at age 12. The effect was most pronounced...
Whiteboard Tactics Unlock Major NHS Negotiation Wins
The Whiteboard Windfall: A Lesson in NHS Negotiations by @Timothy_Hughes https://t.co/2JqnBxsbKP @DLAIgnite #SocialSelling #DigitalSelling #Sales #SalesTips #SalesLeader #Salesforce #SalesEnablement #RevOps #Leadership #Marketing #SalesNegotiation https://t.co/XpSE4j8Xm8
What’s the Breast Reconstruction Timeline After Surgery for Breast Cancer?
Early-stage breast cancer patients can choose between immediate or two‑stage reconstruction after mastectomy. Immediate reconstruction merges tumor removal and breast rebuilding in one operation, while two‑stage reconstruction uses a tissue expander followed by a second surgery. The overall timeline for...
Kits Eyecare Appoints Tai Silvey as President
Kits Eyecare Ltd. promoted Tai Silvey to President, tasking him with day‑to‑day oversight of supply chain, customer experience and commercial execution. Silvey, who joined in 2022 and previously led business development, brings two decades of scaling experience at Red Bull and...
FDA’s CRL Transparency Policy Is Boosting Biopharma Accountability
More than a year after the FDA launched its radical transparency agenda, the agency has released over 200 complete response letters (CRLs) covering 2020‑2024 and added historic letters back to 2002. Public availability forces biotech firms to align their disclosures...
Body Clocks and Mental Health: Patients Set the Research Agenda
A new BMJ Mental Health study used the James Lind Alliance method to identify the top ten research priorities linking circadian rhythms and mental health. The priority‑setting partnership involved 247 respondents in an initial survey and 222 participants in a...
Weight-Loss Drugs and Mars Bars: Novo Nordisk’s Comeback Bid
Novo Nordisk is launching a next‑generation obesity drug to revive growth after a slowdown in its diabetes franchise. The company projects $5 billion in sales from the new semaglutide‑based therapy by 2028, targeting a global obesity market estimated at $250 billion. To...
Weizmannia Coagulans BC99 Presents Promising Probiotic Strategy for Chronic Constipation
A double‑blind, placebo‑controlled trial of 88 adults showed that daily intake of Weizmannia coagulans BC99 (10 billion CFU) for eight weeks markedly improved bowel‑movement frequency, stool form and psychological well‑being. Participants receiving BC99 experienced faster colonic transit, higher levels of motility‑promoting peptides and...
Aspirin May Fight Cancer — But Not for the Reason You Think
Researchers at Tahoe Therapeutics assembled a 100‑million‑cell dataset to ask whether drugs can push cancer cells back toward a normal gene program. Using this approach, they confirmed known colon‑cancer therapies and discovered that sodium salicylate—aspirin without its acetyl group—reverses cancer‑state...
Preferred Provider Organization (PPO): Definition and Benefits
A Preferred Provider Organization (PPO) is a health‑insurance plan that lets members see any doctor, in‑ or out‑of‑network, without needing a primary‑care physician or specialist referrals. PPOs negotiate lower fees with a broad network of providers, but they charge higher...
Frontpoint Health Names New CEO
Frontpoint Health announced that Jay Wendt will replace Brent Korte as chief executive officer. Wendt comes from a background leading Stance Health Solutions, a durable medical equipment firm, and previously ran Martin Bionics. The Dallas‑based provider, backed by Cimarron Healthcare...
AI Could Make MEDVi $1b in Sales – but It Could Also Break It
MEDVi, an online GLP‑1 weight‑loss drug retailer, posted $401 million in 2025 sales and is projected to reach $1.8 billion in 2026 after scaling from a $20,000, two‑person AI‑built operation. Founder Matthew Gallagher leveraged generative AI for everything from code to customer...
Stanford Scientists Discover “Natural Ozempic” Without Side Effects
Stanford Medicine scientists have identified a naturally occurring 12‑amino‑acid peptide, dubbed BRP, that mimics the appetite‑suppressing effects of semaglutide (Ozempide) in animal models. In lean mice and minipigs, a single injection cut food intake by up to 50% and daily...